首页> 外文期刊>Epigenetics: official journal of the DNA Methylation Society >Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma
【24h】

Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma

机译:默克尔细胞癌中富含H3K27Ac的增强子区域BRD4的破坏与c-Myc表达降低有关

获取原文
获取原文并翻译 | 示例
           

摘要

Pathologic c-Myc expression is frequently detected in human cancers, including Merkel cell carcinoma (MCC), an aggressive skin cancer with no cure for metastatic disease. Bromodomain protein 4 (BRD4) regulates gene transcription by binding to acetylated histone H3 lysine 27 (H3K27Ac) on the chromatin. Super-enhancers of transcription are identified by enrichment of H3K27Ac. BET inhibitor JQ1 disrupts BRD4 association with super-enhancers, downregulates proto-oncogenes, such as c-Myc, and displays antitumor activity in preclinical animal models of human cancers. Here we show that an enhancer proximal to the c-Myc promoter is enriched in H3K27Ac and associated with high occupancy of BRD4, and coincides with a putative c-Myc super-enhancer in MCC cells. This observation is mirrored in tumors from MCC patients. Importantly, depleted BRD4 occupancy at the putative c-Myc super-enhancer region by JQ1 correlates with decreased c-Myc expression. Thus, our study provides initial evidence that super-enhancers regulate c-Myc expression in MCC.
机译:在人类癌症中经常检测到病理性c-Myc表达,包括默克尔细胞癌(MCC),这是一种无法治愈转移性疾病的侵袭性皮肤癌。 Bromodomain蛋白4(BRD4)通过与染色质上的乙酰化组蛋白H3赖氨酸27(H3K27Ac)结合来调节基因转录。通过富集H3K27Ac来鉴定转录的超级增强子。 BET抑制剂JQ1破坏了BRD4与超级增强子的结合,下调了原癌基因,例如c-Myc,并在人类癌症的临床前动物模型中显示出抗肿瘤活性。在这里,我们显示了接近c-Myc启动子的增强子富含H3K27Ac,并与BRD4的高占用率相关,并且与MCC细胞中推定的c-Myc超增强剂相吻合。该观察结果反映在来自MCC患者的肿瘤中。重要的是,JQ1在假定的c-Myc超级增强子区域消耗的BRD4占用与c-Myc表达降低有关。因此,我们的研究提供了超级增强剂调节MCC中c-Myc表达的初步证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号